[go: up one dir, main page]

BE788897A - Medicament a base d'esters de dehydroepiandrosterone - Google Patents

Medicament a base d'esters de dehydroepiandrosterone

Info

Publication number
BE788897A
BE788897A BE788897DA BE788897A BE 788897 A BE788897 A BE 788897A BE 788897D A BE788897D A BE 788897DA BE 788897 A BE788897 A BE 788897A
Authority
BE
Belgium
Prior art keywords
medicinal product
dehydroepiandrosterone
esters
dehydroepiandrosterone esters
medicinal
Prior art date
Application number
Other languages
English (en)
French (fr)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of BE788897A publication Critical patent/BE788897A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
BE788897D 1971-09-17 Medicament a base d'esters de dehydroepiandrosterone BE788897A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2147309A DE2147309A1 (de) 1971-09-17 1971-09-17 Arzneimittel auf basis von dehydroepiandrosteronestern

Publications (1)

Publication Number Publication Date
BE788897A true BE788897A (fr) 1973-03-15

Family

ID=5820276

Family Applications (1)

Application Number Title Priority Date Filing Date
BE788897D BE788897A (fr) 1971-09-17 Medicament a base d'esters de dehydroepiandrosterone

Country Status (4)

Country Link
BE (1) BE788897A (xx)
DE (1) DE2147309A1 (xx)
NL (1) NL7212595A (xx)
ZA (1) ZA726325B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19618778A1 (de) * 1995-05-12 1997-01-23 Stefan Dr Schulz Verwendung von Dehydroepiandrosteron und Derivaten hiervon
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy

Also Published As

Publication number Publication date
NL7212595A (xx) 1973-03-20
ZA726325B (en) 1973-06-27
DE2147309A1 (de) 1973-03-22

Similar Documents

Publication Publication Date Title
BE833762A (fr) Supports pour medicaments
CA981582A (en) Coronary dilator in a pharmaceutical dosage unit form
BE791632A (fr) Supports a base de caoutchouc siliconique pour agents medicamenteux
FR2304348A1 (fr) Medicament a base de sulfadiazine zincique
BE755320A (fr) Etiquette pour l'etude clinique aveugle d'un medicament
JPS54494A (en) Medicine administering instrument
FR2307541A1 (fr) Medicament a base d'un polypeptide
BE767707A (fr) Medicament a base d'un derive de l'aminoacetonitrile
BE788322A (fr) 3,4-dihydro-2h-isoquinoleine-1-ones et medicaments qui en contiennent
BE788897A (fr) Medicament a base d'esters de dehydroepiandrosterone
BE787523A (fr) Medicament a base de pyridone-2
BE816376A (fr) Compositions pharmaceutiques a base de creatine-phosphate et decreatine-phosphokinase
BE806158A (fr) Medicament a base d'ergocornine ou de 2-bromo-alpha-ergokryptine
BE770844A (fr) Medicament a base d'un derive de diphenyl-alcane
BE819833A (fr) Medicament a base de beta-1-glycoproteine
BE771112A (fr) Medicament a base d'un derive de l'aminoguanidine
BE823485A (fr) Nouveau medicament a base de vincamine
BE823487A (fr) Medicament a base de vincamine
BE811547A (fr) Medicament a base d'un derive de la 7h-benzocycloheptene-7-one
BE762671A (fr) Medicament a base d'un derive de la p-phenylenediamine
BE771007A (fr) Medicament a base d'acide 4-hydroxynicotinique
BE792916A (fr) Medicament a activite antipeptique
FR2333507A1 (fr) Medicament a base de substances possedant le squelette de l'eburnane
BE801014A (fr) Medicament a base d'(hydroxy-2 indanyl-2)1 propylamine
BE787908A (fr) Medicament antidepressif et antiparkinsonien